Kailera Therapeutics, Inc. (KLRA)
10.84
-0.49
(-4.32%)
USD |
NASDAQ |
Oct 13, 14:59
Kailera Therapeutics Total Liabilities (Quarterly) : 92.95M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.95M |
| Date | Value |
|---|---|
| March 31, 2026 | 64.48M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Twist Bioscience Corp. | 226.70M |
| Prime Medicine, Inc. | 209.23M |
| GRAIL, Inc. | 301.03M |
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.211B |
| Shareholders Equity (Quarterly) | 1.118B |
| Debt to Equity Ratio | 0.0091 |
| Current Ratio | 11.11 |